Janus Henderson Group
RARE icon

Janus Henderson Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Janus Henderson Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$765K Hold
36,543
– – ﹤0.01% 1808
2025
Q4 		$840K Hold
36,543
– – ﹤0.01% 1763
2025
Q3 		$1.1M Hold
36,543
– – ﹤0.01% 1611
2025
Q2 		$1.33M Hold
36,543
– – ﹤0.01% 1482
2025
Q1 		$1.38M Hold
36,543
– – ﹤0.01% 1461
2024
Q4 		$1.54M Hold
36,543
– – ﹤0.01% 1454
2024
Q3 		$2.03M Sell
36,543
-35,200
-49% -$1.79M ﹤0.01% 1306
2024
Q2 		$2.95M Buy
71,743
+39,592
+123% +$1.69M ﹤0.01% 1076
2024
Q1 		$1.5M Buy
32,151
+13
+0% +$613 ﹤0.01% 1423
2023
Q4 		$1.54M Hold
32,138
– – ﹤0.01% 1388
2023
Q3 		$1.15M Buy
32,138
+8
+0% +$317 ﹤0.01% 1489
2023
Q2 		$1.48M Sell
32,130
-35
-0.1% -$1.62K ﹤0.01% 1400
2023
Q1 		$1.29M Buy
32,165
+19,234
+149% +$825K ﹤0.01% 1482
2022
Q4 		$599K Sell
12,931
-12,929
-50% -$509K ﹤0.01% 1621
2022
Q3 		$1.07M Buy
25,860
+12,934
+100% +$665K ﹤0.01% 1606
2022
Q2 		$772K Buy
12,926
+10
+0.1% +$615 ﹤0.01% 1486
2022
Q1 		$938K Sell
12,916
-23,772
-65% -$1.65M ﹤0.01% 1551
2021
Q4 		$3.09M Sell
36,688
-61,841
-63% -$5.03M ﹤0.01% 1174
2021
Q3 		$8.89M Buy
+98,529
New +$8.91M ﹤0.01% 935

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group's RARE Position: Q1 2026 in Review

Janus Henderson Group held its Ultragenyx Pharmaceutical (RARE) position steady in Q1 2026 at 36,543 shares worth $765K. The position accounts for ﹤0.01% of the portfolio, ranked #1808.

Janus Henderson Group first reported a position in RARE in Q3 2021 and has held it in 19 quarters since. The position peaked at $8.89M in Q3 2021. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Janus Henderson Group held 36,543 shares of Ultragenyx Pharmaceutical worth $765K as of Q1 2026.
  • Janus Henderson Group left its Ultragenyx Pharmaceutical share count unchanged in Q1 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1808 holding.
  • Janus Henderson Group first reported a position in Ultragenyx Pharmaceutical in Q3 2021 and has held it in 19 quarters since.
  • Janus Henderson Group's Ultragenyx Pharmaceutical position peaked at $8.89M in Q3 2021.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.